11.1 Information on toxicological effects
Acute toxicity
LD50 Oral - Rat - male and female - 5,150 mg/kg (OECD Test Guideline 401)
Remarks: The value is given in analogy to the following substances: 1,4-Dioxane
Symptoms: mucosal irritations, Cough, Shortness of breath, Possible damages:, damage of respiratory tract, Lung edema
LD50 Dermal - Rabbit - 7,378 mg/kg
Remarks: (RTECS)
The value is given in analogy to the following substances: 1,4-Dioxane
Skin corrosion/irritation
Skin - Rabbit
Result: No skin irritation - 20 h
Remarks: (IUCLID)
Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2)
The value is given in analogy to the following substances: 1,4-Dioxane
Serious eye damage/eye irritation
Eyes - Rabbit
Result: Eye irritation (OECD Test Guideline 405)
Remarks: The value is given in analogy to the following substances: 1,4-Dioxane
Remarks: (Regulation (EC) No 1272/2008, Annex VI)
Respiratory or skin sensitization
Maximization Test - Guinea pig
Result: negative (Regulation (EC) No. 440/2008, Annex, B.6)
Remarks: The value is given in analogy to the following substances: 1,4-Dioxane
Germ cell mutagenicity
Test Type: Ames test
Test system: Salmonella typhimurium
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: negative
Remarks: The value is given in analogy to the following substances: 1,4-DioxaneTest Type:
In vitro mammalian cell gene mutation test
Test system: Chinese hamster ovary cells
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 476
Result: negative
Remarks: The value is given in analogy to the following substances: 1,4-DioxaneTest Type:
Chromosome aberration test in vitro
Test system: Chinese hamster ovary cells
Metabolic activation: with and without metabolic activation
Result: negative
Remarks: (ECHA)
The value is given in analogy to the following substances: 1,4-Dioxane
Test Type: unscheduled DNA synthesis assay
Species: Rat
Cell type: Liver cells
Application Route: Oral
Result: negative
Remarks: (ECHA)
The value is given in analogy to the following substances: 1,4-Dioxane
Carcinogenicity
Presumed to have carcinogenic potential for humans
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
May cause respiratory irritation. - Respiratory system
Remarks: Classified according to Regulation (EU) 1272/2008, Annex VI (Table 3.1/3.2)
The value is given in analogy to the following substances: 1,4-Dioxane
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
Repeated dose toxicity - Rat - male - Oral - 716 Days - NOAEL (No observed adverse effect level) - 9.6 mg/kg
Remarks: (ECHA)
The value is given in analogy to the following substances: 1,4-Dioxane
Nausea, Vomiting, Weakness, Dizziness, Vertigo, Headache, Sweating, loss of appetite,
Kidney injury may occur., Liver injury may occur.
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.
The substance has delayed effects.
After absorption:
Headache
Dizziness
Nausea
Vomiting
Absorption can result in damage to:
Liver
Kidney
Other dangerous properties can not be excluded.
This substance should be handled with particular care.